Boehringer Ingelheim and DeveloGen AG announce agreement
- Details
- Category: Boehringer Ingelheim

Roche provides additional donation of 5.65 million packs of Tamiflu to WHO
- Details
- Category: Roche

- Replenishment of the Regional Stockpile of 2 million treatment courses of Tamiflu to be held by the WHO and used to address regional outbreaks,
Sanofi-aventis builds a New Vaccine Manufacturing Facility in France
- Details
- Category: Sanofi

AstraZeneca Announces Top Line Results From Pivotal Phase III Study for BRILINTA
- Details
- Category: AstraZeneca

Novo Nordisk reaches settlements regarding Oil-for-Food activities
- Details
- Category: Novo Nordisk

Nycomed files European marketing authorisation application for Daxas®
- Details
- Category: Nycomed

GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million
- Details
- Category: GlaxoSmithKline

More Pharma News ...
- Bayer Schering Pharma is starting Phase III studies with an innovative low-dose contraceptive patch
- Pfizer And Wisconsin Alumni Research Foundation (WARF) Sign License Agreement
- GlaxoSmithKline update: influenza A (H1N1)
- Outcome of new Mirapexin®/Sifrol® (pramipexole) study
- Bayer and Ardea Biosciences Enter Global Agreement Focused on the Development of MEK Inhibitors
- Pfizer Reports First-Quarter 2009 Results
- Q1/2009: Merck Revenues Remain Stable at € 1.9 Billion